- Home
- CNNE vs INMD Comparison
CNNE vs INMD Comparison
Compare CNNE & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNNE
- INMD
- Stock Information
- Founded
- CNNE 2014
- INMD 2008
- Country
- CNNE United States
- INMD Israel
- Employees
- CNNE N/A
- INMD N/A
- Industry
- CNNE Restaurants
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CNNE Consumer Discretionary
- INMD Health Care
- Exchange
- CNNE Nasdaq
- INMD Nasdaq
- Market Cap
- CNNE 1.1B
- INMD 1.3B
- IPO Year
- CNNE N/A
- INMD 2019
- Fundamental
- Price
- CNNE $17.31
- INMD $14.92
- Analyst Decision
- CNNE Buy
- INMD Buy
- Analyst Count
- CNNE 2
- INMD 5
- Target Price
- CNNE $22.50
- INMD $21.25
- AVG Volume (30 Days)
- CNNE 841.5K
- INMD 1.9M
- Earning Date
- CNNE 05-08-2025
- INMD 04-28-2025
- Dividend Yield
- CNNE 2.77%
- INMD N/A
- EPS Growth
- CNNE N/A
- INMD N/A
- EPS
- CNNE N/A
- INMD 2.25
- Revenue
- CNNE $452,500,000.00
- INMD $394,818,000.00
- Revenue This Year
- CNNE N/A
- INMD $2.02
- Revenue Next Year
- CNNE $2.23
- INMD $5.47
- P/E Ratio
- CNNE N/A
- INMD $6.63
- Revenue Growth
- CNNE N/A
- INMD N/A
- 52 Week Low
- CNNE $15.92
- INMD $13.68
- 52 Week High
- CNNE $22.36
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- CNNE 46.44
- INMD 36.82
- Support Level
- CNNE $17.14
- INMD $14.67
- Resistance Level
- CNNE $17.82
- INMD $15.54
- Average True Range (ATR)
- CNNE 0.70
- INMD 1.08
- MACD
- CNNE 0.01
- INMD -0.12
- Stochastic Oscillator
- CNNE 44.64
- INMD 24.88
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.